1. Home
  2. POAI vs GRNQ Comparison

POAI vs GRNQ Comparison

Compare POAI & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • GRNQ
  • Stock Information
  • Founded
  • POAI 2002
  • GRNQ 2013
  • Country
  • POAI United States
  • GRNQ Malaysia
  • Employees
  • POAI N/A
  • GRNQ N/A
  • Industry
  • POAI Industrial Specialties
  • GRNQ EDP Services
  • Sector
  • POAI Health Care
  • GRNQ Technology
  • Exchange
  • POAI Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • POAI 9.7M
  • GRNQ 8.9M
  • IPO Year
  • POAI N/A
  • GRNQ 2018
  • Fundamental
  • Price
  • POAI $1.62
  • GRNQ $1.09
  • Analyst Decision
  • POAI Hold
  • GRNQ
  • Analyst Count
  • POAI 1
  • GRNQ 0
  • Target Price
  • POAI N/A
  • GRNQ N/A
  • AVG Volume (30 Days)
  • POAI 2.7M
  • GRNQ 38.6K
  • Earning Date
  • POAI 03-27-2025
  • GRNQ 03-27-2025
  • Dividend Yield
  • POAI N/A
  • GRNQ N/A
  • EPS Growth
  • POAI N/A
  • GRNQ N/A
  • EPS
  • POAI N/A
  • GRNQ N/A
  • Revenue
  • POAI $1,484,223.00
  • GRNQ $2,727,344.00
  • Revenue This Year
  • POAI N/A
  • GRNQ N/A
  • Revenue Next Year
  • POAI $569.48
  • GRNQ N/A
  • P/E Ratio
  • POAI N/A
  • GRNQ N/A
  • Revenue Growth
  • POAI N/A
  • GRNQ N/A
  • 52 Week Low
  • POAI $0.55
  • GRNQ $0.80
  • 52 Week High
  • POAI $3.76
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • POAI 62.46
  • GRNQ 51.12
  • Support Level
  • POAI $1.37
  • GRNQ $0.97
  • Resistance Level
  • POAI $1.58
  • GRNQ $1.13
  • Average True Range (ATR)
  • POAI 0.13
  • GRNQ 0.06
  • MACD
  • POAI -0.01
  • GRNQ 0.01
  • Stochastic Oscillator
  • POAI 93.55
  • GRNQ 77.24

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

Share on Social Networks: